Covid-19 Rates by Time since Vaccination during Delta Variant Predominance

With the emergence of the delta variant, the United States experienced a rapid increase in Covid-19 cases in 2021. We estimated the risk of breakthrough infection and death by month of vaccination as a proxy for waning immunity during a period of delta variant predominance. Covid-19 case and death d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:NEJM evidence Jg. 1; H. 3
Hauptverfasser: Paz-Bailey, Gabriela, Sternberg, Maya, Kugeler, Kiersten, Hoots, Brooke, Amin, Avnika B., Johnson, Amelia G., Barbeau, Bree, Bayoumi, Nagla S., Bertolino, Daniel, Boulton, Rachelle, Brown, Catherine M., Busen, Katherine, Cima, Michael, Drenzek, Cherie, Gent, Ashley, Haney, Gillian, Hicks, Liam, Hook, Sarah, Jara, Amanda, Jones, Amanda, Kamal-Ahmed, Ishrat, Kangas, Sarah, Kanishka, F.N.U., Khan, Saadiah I., Kirkendall, Samantha K., Kocharian, Anna, Lyons, B. Casey, Lauro, Priscilla, McCormick, Donald, McMullen, Chelsea, Milroy, Lauren, Reese, Heather E., Sell, Jessica, Sierocki, Allison, Smith, Elizabeth, Sosin, Daniel, Stanislawski, Emma, Strand, Kyle, Troelstrup, Thomas, Turner, Kathryn A., Vest, Hailey, Warner, Sydni, Wiedeman, Caleb, Silk, Benjamin, Scobie, Heather M.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 10.01.2022
ISSN:2766-5526, 2766-5526
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:With the emergence of the delta variant, the United States experienced a rapid increase in Covid-19 cases in 2021. We estimated the risk of breakthrough infection and death by month of vaccination as a proxy for waning immunity during a period of delta variant predominance. Covid-19 case and death data from 15 U.S. jurisdictions during January 3 to September 4, 2021 were used to estimate weekly hazard rates among fully vaccinated persons, stratified by age group and vaccine product. Case and death rates during August 1 to September 4, 2021 were presented across four cohorts defined by month of vaccination. Poisson models were used to estimate adjusted rate ratios comparing the earlier cohorts to July rates. During August 1 to September 4, 2021, case rates per 100,000 person-weeks among all vaccine recipients for the January to February, March to April, May to June, and July cohorts were 168.8 (95% confidence interval [CI], 167.5 to 170.1), 123.5 (95% CI, 122.8 to 124.1), 83.6 (95% CI, 82.9 to 84.3), and 63.1 (95% CI, 61.6 to 64.6), respectively. Similar trends were observed by age group for BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccine recipients. Rates for the Ad26.COV2.S (Janssen-Johnson & Johnson) vaccine were higher; however, trends were inconsistent. BNT162b2 vaccine recipients 65 years of age or older had higher death rates among those vaccinated earlier in the year. Protection against death was sustained for the mRNA-1273 vaccine recipients. Across age groups and vaccine types, people who were vaccinated 6 months ago or longer (January-February) were 3.44 (3.36 to 3.53) times more likely to be infected and 1.70 (1.29 to 2.23) times more likely to die from COVID-19 than people vaccinated recently in July 2021. Our study suggests that protection from SARS-CoV-2 infection among all ages or death among older adults waned with increasing time since vaccination during a period of delta predominance. These results add to the evidence base that supports U.S. booster recommendations, especially for older adults vaccinated with BNT162b2 and recipients of the Ad26.COV2.S vaccine. (Funded by the Centers for Disease Control and Prevention.).
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2766-5526
2766-5526
DOI:10.1056/EVIDoa2100057